Unlisted
| Company Name | 이엔셀(주) |
| English Name | ENCell Co., Ltd. |
| Business Reg. No. | 3608601147 |
| CEO | 장종욱 |
| Address | 서울특별시 송파구 송파대로 201 17층(송파테라타워2 A동) |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Main Products | 세포유전자치료제 |
| Established | Contact |
| Phone | 02-6205-8050 |
| Website | www.encellinc.com/ |
| Regular Employees | 107persons |
| Corp. Reg. No. | 1101116693918 |
Venture Certified
| 벤처투자유형 | 2018-06-21 ~ 2020-06-20 | 20180300467 | 2018-06-21 |
| 벤처투자유형 | 2020-06-21 ~ 2022-06-20 | 20200300596 | 2018-06-21 |
| 벤처투자유형 | 2022-06-21 ~ 2025-06-20 | 20220609010032 | 2018-06-21 |
| 연구개발유형 | 2025-06-21 ~ 2028-06-20 | 20250729020017 | 2018-06-21 |
Revenue CAGR -1.1%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 72B | 105B | 74B |
| Operating Profit | -157B | -118B | -93B |
| Net Profit | -152B | -51B | -456B |
| Total Assets | 557B | 440B | 547B |
| Total Liabilities | 76B | 60B | 786B |
| Total Equity | 482B | 380B | -238B |
Operating Loss: Op. profit -157B
Revenue down 32% YoY
3 Consecutive Years of Net Loss
▼ 19.4%
▼ 48.9%
▼ 82.7%
▲ 110.0%
▼ 135.5%
| Name | Position | Role |
|---|---|---|
| 장종욱 | 대표이사 | 대표 |
| NPS Subscribers | 107persons |
| CEO | 장종욱 |
| Est. Avg. Annual Salary | 4,97510K (41510K/mo) |
| Hired (12 mo) | +2persons |
| Left (12 mo) | -3persons |
| Net Change (12 mo) | -1persons |
| NPS Join Date | 2018-04-05 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 송파구 송파대로",
"brno": "360860****",
"cappedWarning": false,
"companyName": "이엔셀주식회사",
"estimatedAvgAnnualSalary": 49750524,
"estimatedAvgMonthlySalary": 4145877,
"fetchedAt": "2026-03-05T11:35:53.939Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20180405",
"last12MonthsHired": 2,
"last12MonthsLeft": 3,
"last12MonthsNetChange": -1,
"leaveDate": null,
"monthlyPensionAmount": 42142840,
"monthlyTrend": [
{
"lostSubscribers": 3,
"newSubscribers": 2,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6790180",
"status": "1",
"styleCode": "1",
"subscriberCount": 107,
"turnoverMonths": 1
}{
"address": "서울 송파구",
"ceo_name": "장종욱",
"certificate": [
{
"cert_number": "20180300467",
"changes": "",
"disclosure_date": "2018-06-21",
"first_cert_date": "2018-06-21",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2018-06-21 ~ 2020-06-20"
},
{
"cert_number": "20200300596",
"changes": "",
"disclosure_date": "2020-05-21",
"first_cert_date": "2018-06-21",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2020-06-21 ~ 2022-06-20"
},
{
"cert_number": "20220609010032",
"changes": "",
"disclosure_date": "2022-06-09",
"first_cert_date": "2018-06-21",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2022-06-21 ~ 2025-06-20"
},
{
"cert_number": "20250729020017",
"changes": "",
"disclosure_date": "2025-07-29",
"first_cert_date": "2018-06-21",
"no": "4",
"type": "연구개발유형",
"valid_period": "2025-06-21 ~ 2028-06-20"
}
],
"company_name": "이엔셀 주식회사",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 122394000,
"cost_of_sales": 6699827000,
"current_assets": 31644291000,
"current_liabilities": 74430247000,
"gross_profit": 667535000,
"net_income": -45566953000,
"net_income_bs": -45566953000,
"non_current_assets": 23102006000,
"non_current_liabilities": 4151927000,
"non_operating_expenses": 36815505000,
"non_operating_income": 563994000,
"operating_profit": -9315442000,
"revenue": 7367362000,
"sga_expenses": 9982977000,
"total_assets": 54746297000,
"total_equity": -23835877000,
"total_liabilities": 78582174000
},
"2023": {
"capital_stock": 4415688000,
"cost_of_sales": 10883450000,
"current_assets": 22928326000,
"current_liabilities": 2742451000,
"gross_profit": -357563000,
"net_income": -5053520000,
"net_income_bs": -5053520000,
"non_current_assets": 21052825000,
"non_current_liabilities": 3222368000,
"non_operating_expenses": 1931753000,
"non_operating_income": 8633290000,
"operating_profit": -11755057000,
"revenue": 10525887000,
"sga_expenses": 11397494000,
"total_assets": 43981151000,
"total_equity": 38016332000,
"total_liabilities": 5964819000
},
"2024": {
"capital_stock": 5383089000,
"cost_of_sales": 10194180000,
"current_assets": 35544729000,
"current_liabilities": 2688729000,
"gross_profit": -2984862000,
"net_income": -15209839000,
"net_income_bs": -15209839000,
"non_current_assets": 20200285000,
"non_current_liabilities": 4888120000,
"non_operating_expenses": 428198000,
"non_operating_income": 901469000,
"operating_profit": -15683110000,
"revenue": 7209317000,
"sga_expenses": 12698248000,
"total_assets": 55745014000,
"total_equity": 48168165000,
"total_liabilities": 7576849000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "2,166,000,000",
"changes": "2,166,000,000",
"date": "2021-05-28"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2021-05-28"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2021-04-23"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2021-04-23"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2020-02-14"
},
{
"amount": "666,000,000",
"changes": "666,000,000",
"date": "2020-02-14"
},
{
"amount": "666,000,000",
"changes": "666,000,000",
"date": "2020-02-14"
},
{
"amount": "300,000,000",
"changes": "300,000,000",
"date": "2018-05-29"
}
],
"main_products": "세포유전자치료제",
"phone": "02-6205-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |